terpenoid

(redirected from Triterpenoid)
Also found in: Medical, Encyclopedia.

ter·pene

 (tûr′pēn′)
n.
Any of various unsaturated hydrocarbons, C10H16, found in essential oils and oleoresins of plants such as conifers and used in organic syntheses.

[Obsolete terp(entine), variant of turpentine + -ene.]

ter·pe′nic adj.
ter′pe·noid′ adj. & n.

terpenoid

(ˈtɜːpəˌnɔid) chem
n
(Chemistry) a class of chemical compounds including all terpenes
adj
(Chemistry) relating to terpenes
References in periodicals archive ?
Integracides: Tetracyclic Triterpenoid Inhibitors of HIV-1 Integrase Produced by Fusarium Sp.
The company's lead product candidate, SCY-078, is the first representative of a novel oral and IV triterpenoid antifungal family and is in Phase 2 clinical development for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections.
In addition to playing a complementary role with beta-glucans in immune system activation, triterpenoid actions are also hepatoprotective, lipid lowering, antioxidant, anti-inflammatory, and inhibit histamine release.
Ethanol extraction of plant lead to highly oxygenated mostly polar bioactive compounds like triterpenes, triterpenoid and glycosides (Bhat, 2005).
Ursolic acid (3beta-hydroxy-urs-12-en-28-oic acid) is a pentacyclic triterpenoid found naturally in apples, waxy berries, rosemary, oregano, and several other plants and herbs used in medicine and the diet.
Also known as gotu kola, Centella asiatica contains triterpenoid compounds that help stabilize soft plaque by improving the synthesis of collagen, (10-13) a component of the thick caps that hold soft plaque in place.
A triterpenoid index was calculated to reveal the triterpenoid composition of oak.
Profiling of triterpenoid saponin content variation in different chemotypic accessions of Centella asiatica L.
This contribution may be due to the biocidal aspects of triterpenoid saponins, the main component of the plant extract, which may have favoured the sanitation of the root environment, possibly acting on nematodes, which damage the root system (Ritzinger, Borges, Ledo, & Caldas, 2007), resulting in better root development than with only HS application.
Drug development company SCYNEXIS (NasdaqGM:SCYX) revealed on Wednesday the receipt of the orphan drug designation from the US Food and Drug Administration (FDA) has for the novel triterpenoid broad-spectrum antifungal agent, SCY-078, for the treatment of invasive Aspergillus infections.
In addition, the triterpenoid compounds isolated from leaves of Diospyros kaki also have effect of suppressing N-formyl-methionyl-leucylphenylalanine (fMLP)-induced superoxide generation (Chen et al.